The U.S. FDA granted approval to Cochlear Ltd’s Nucleus Nexa System, the first smart cochlear implant incorporating advanced technology for hearing restoration. Anticipated for U.S. launch within months, the implant offers enhanced functionality and connectivity features. Brendan Murray, CVP for the cochlear implant portfolio, noted the approval as a significant milestone, reflecting recent innovations in implantable auditory devices targeting improved patient outcomes.